VistaGen Therapeutics
VTGN
#9358
Rank
โ‚ฌ56.35 M
Marketcap
1,95ย โ‚ฌ
Share price
-5.13%
Change (1 day)
-55.42%
Change (1 year)

EPS for VistaGen Therapeutics (VTGN)

EPS in 2023 (TTM): -6,18ย โ‚ฌ

According to VistaGen Therapeutics 's latest financial reports the company's current EPS (TTM) is -5,67ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -8,22ย โ‚ฌ an increase over its 2021 EPS that were of -8,54ย โ‚ฌ.

EPS history for VistaGen Therapeutics from 2008 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-6,18ย โ‚ฌ-24.84%
2022-8,22ย โ‚ฌ-3.71%
2021-8,54ย โ‚ฌ24.49%
2020-6,86ย โ‚ฌ-55.17%
2019-15,31ย โ‚ฌ-37.59%
2018-24,52ย โ‚ฌ-32.16%
2017-36,15ย โ‚ฌ-72.04%
2016-129,30ย โ‚ฌ-84.16%
2015-816,44ย โ‚ฌ298.71%
2014-204,77ย โ‚ฌ83.45%
2013-111,62ย โ‚ฌ-83.24%
2012-665,83ย โ‚ฌ93.91%
2011-343,38ย โ‚ฌ
2010N/A
2009N/A
2008N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ-66.20%๐Ÿ‡บ๐Ÿ‡ธ USA